Bellicum Pharmaceuticals (BLCM) Financials

$0.07

$-0.13 (-62.65%)

As on 04-Mar-2024 14:59EDT

Market cap

$1 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

40.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1.51	1.50	6.20	0.50	7.14	1.12
Cost of Revenue	--	--	--	--	62.47	0.44
Gross Profit	1.51	1.50	6.20	0.50	7.14	1.12
Operating Expenses	25.33	28.48	30.59	54.58	94.51	96.59
Operating Profit (EBIT)	-23.05	-26.98	-24.87	-51.69	-87.36	-95.47
Other Income	--	--	--	46.63	-20.83	1.63
Profit before Tax	-22.38	-24.97	-9.71	-7.72	-112.48	-98.04
Provision for Tax	-0.30	0.00	-0.13	0.90	13.62	1.63
Profit after Tax (Net Income)	-21.80	-24.97	-9.58	-8.62	-126.09	-98.04
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-22.06	--	-9.71	-7.72	-112.48	-98.04

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-27.01	2.02	24.40	-2.50	-26.22	68.48
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	31.62	18.04	18.04	18.38	48.05	37.22
Current Liabilities	2.25	3.77	6.71	24.70	94.42	15.80
Total Liabilities	9.10	23.82	49.14	40.58	116.25	121.50

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.01	0.02	0.01	1.14	4.40	26.21
Current Assets	6.85	23.80	49.13	39.44	111.85	95.30
Total Assets	9.10	23.82	49.14	40.58	116.25	121.50
Total Debt*	--	--	--	1.17	38.04	35.96
Net Current Assets	4.60	20.03	42.42	14.74	17.44	79.49

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-25.78	-23.11	-56.65	-77.57	-74.78
Cash Flow from Investing Activities	--	--	0.89	14.08	48.86	10.41
Cash from Financing Activities	--	32.91	32.87	-14.24	74.09	68.11
Net Cash Inflow / Outflow	--	--	--	-56.81	45.38	3.74

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.58	-4.34	-0.61	-1.09	-25.31	-22.60
Cash EPS ($)	--	-4.33	-0.60	-0.85	-23.60	-21.05
Adjusted Book Value ($)	--	0.35	1.54	--	--	15.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.48	-1.46	-7.14	-15.57	-17.24
Free Cash Flow per Share ($)	--	-4.48	-1.46	-7.22	-15.68	-17.61

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-189.12	-83.05	-164.33	-216.92	-87.46
ROE (%)	--	-189.12	-87.48	60.03	-596.73	-128.05
ROA (%)	-94.50	-68.45	-21.35	-10.99	-106.07	-76.28
EBIT Margin (%)	-1,509.75	-1,798.73	-401.06	-10,338.40	-1,223.07	-8,523.75
Net Margin (%)	-1,445.42	-1,664.87	-154.48	-18.29	921.05	-3,566.24
Cash Profit Margin (%)	-0.16	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	0.53	-0.76	11.40	-0.93	5.38	5.05
EBIT Growth (%)	7.99	-8.51	51.90	40.83	8.49	-10.58
Net Profit Growth (%)	-41.72	-160.73	-11.13	93.16	-28.62	-6.82
EPS Growth (%)	-275.60	-6.16	0.44	0.96	-0.12	0.18
Book Value Growth (%)	-459.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.17	-2.46	-3.25	-0.05	-0.13
Price / Book Value	40.34	2.06	0.97	-11.22	-0.25	0.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.91	0.61	0.93	0.12	0.68	0.50
Close Price ($)	0.33	0.72	1.49	3.53	12.90	29.20
High Price ($)	1.50	2.20	8.15	27.90	41.40	102.60
Low Price ($)	0.15	0.60	1.43	2.62	7.21	27.40
Market Cap ($ Cr)	0.78	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	-0.47	-1.45	0.53
Short term debt to equity ratio	--	--	--	-0.33	-0.44	0.00
Current Ratio	3.04	6.31	7.32	1.60	1.18	6.03
Quick Ratio	3.04	6.36	7.10	1.47	0.98	6.12
Interest Coverage	-36.93	-586,543.48	-6,216.50	-19.44	-20.41	-22.74

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	0.99	13.67	3.31	0.40	4.24	205.00
Asset Turnover	0.07	0.04	0.14	0.01	0.06	0.01
Receivable days	--	49.92	6.10	111.40	66.45	426.56
Inventory Days	--	--	--	--	53.36	-580.97
Payable days	--	--	--	--	18.76	2,957.60
Cash Conversion Cycle	--	--	--	--	101.05	-3,112.01

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.